Silodosin in Management of Lower Ureteral Stones

Syrian Private University100 enrolled

Overview

This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter (right or left), the size of the stone, the degree of hydronephrosis, the rate of stone expulsion(day), whether the stone was completely expelled or not, and the side effects of silodosin.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Stone, Kidney

Interventions

SilodosinDRUG

Selective Alpha Blocker drug

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients attending the urology Clinic with a distal unilateral ureteral stone larger than 6 mm in diameter. Exclusion Criteria: * Patients under 18 years of age * Pregnant women * Patients with whom we were unable to contact * Patients treated with silodosin for another reason * Single kidney patients * Patients with bilateral ureter stones * Patients with deteriorating kidney function * Patients with grades 3rd and 4th of hydronephrosis

Locations (1)

Damascus university

Damascus, Syria

Outcomes

Primary Outcomes

Stone expulsion (yes)

patients who were able to expel the stone

Time frame: 1 year

Stone expulsion (no)

patients who were not able to expel the stone

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.